These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Granulomatous hepatitis secondary to carbamazepine. Levy M; Goodman MW; Van Dyne BJ; Sumner HW Ann Intern Med; 1981 Jul; 95(1):64-5. PubMed ID: 7247130 [TBL] [Abstract][Full Text] [Related]
14. Gold-induced granulomatous hepatitis. Harats N; Ehrenfeld M; Shalit M; Lijovetzky G Isr J Med Sci; 1985 Sep; 21(9):753-6. PubMed ID: 3932253 [No Abstract] [Full Text] [Related]
15. Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects. Feldman JM Pharmacotherapy; 1985; 5(2):43-62. PubMed ID: 3923453 [TBL] [Abstract][Full Text] [Related]
16. Extensive lichenoid drug eruption due to glyburide: a case report and review of the literature. Fox GN; Harrell CC; Mehregan DR Cutis; 2005 Jul; 76(1):41-5. PubMed ID: 16144288 [TBL] [Abstract][Full Text] [Related]
17. Quinine-induced granulomatous hepatitis. Katz B; Weetch M; Chopra S Br Med J (Clin Res Ed); 1983 Jan; 286(6361):264-5. PubMed ID: 6402064 [TBL] [Abstract][Full Text] [Related]
18. Granulomatous hepatitis as a manifestation of quinidine hypersensitivity. Bramlet DA; Posalaky Z; Olson R Arch Intern Med; 1980 Mar; 140(3):395-7. PubMed ID: 7362358 [TBL] [Abstract][Full Text] [Related]
19. A case of glyburide-induced leukocytoclastic vasculitis. Henley JK; Blackmon JA; Fraga GR; Rajpara A; Maz M Dermatol Online J; 2013 Sep; 19(9):19619. PubMed ID: 24050293 [TBL] [Abstract][Full Text] [Related]